PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Aldactone (Spironolactone)- FDA 18 Drug Disease Depression 220,092 1 0.00 -0.97 0.06 0.56
Aldactone (Spironolactone)- FDA 18 Drug Disease Arrhythmia 29,330 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Disease Ventricular Dysfunction 12,856 1 0.00 -0.97 0.06 0.62
Aldactone (Spironolactone)- FDA 18 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Aldactone (Spironolactone)- FDA 18 Drug Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
Aldactone (Spironolactone)- FDA 18 Drug Disease Infertility 35,448 1 0.00 -0.97 0.06 0.60
BMP-2B 18 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.06 0.63
Allopurinol (Zyloprim)- FDA 18 Drug Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.06 0.62
Allopurinol (Zyloprim)- FDA 18 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.06 0.57
Abatacept (Orencia)- FDA 18 Drug Disease Constipation 15,810 1 0.00 -0.97 0.06 0.62
Abatacept (Orencia)- FDA 18 Drug Disease Neutropenia 25,934 1 0.00 -0.97 0.06 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.06 0.65
Angiostatin K1-3 17 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Angiostatin K1-3 17 Target Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Avonex (Interferon beta-1a)- FDA 17 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Pancreatitis Chronic 16 Disease Disease Carcinoma 433,099 1 0.00 -0.97 0.06 0.55
Pancreatitis Chronic 16 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Thromboembolic Disease 3,336 1 0.00 -0.97 0.06 0.66
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Renal Failure 73,993 1 0.00 -0.97 0.06 0.58
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Neuropathy Diabetic 15 Disease Disease Arrhythmia 29,330 1 0.00 -0.97 0.07 0.60
Neuropathy Diabetic 15 Disease Disease Diabetic Retinopathy 14,494 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Hyperlipidemia 15,317 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.07 0.55
Complement Component C3c 15 Target Disease Depression 220,092 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.07 0.53
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
Complement Component C3c 15 Target Disease Viral Disease 2,087 1 0.01 -0.97 0.07 0.67
Complement Component C3c 15 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.07 0.58
Glutathione Transferase Omega-1 14 Target Disease Hypoglycemia 20,698 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Ovarian Cancer 33,996 1 0.00 -0.96 0.07 0.60
Glutathione Transferase Omega-1 14 Target Disease Hyperglycemia 28,168 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.96 0.07 0.62
Glutathione Transferase Omega-1 14 Target Disease Inflammation 252,734 1 0.00 -0.96 0.07 0.56
Arava (Leflunomide)- FDA 14 Drug Disease Tuberculosis 146,217 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Inflammatory Bowel Disease 24,375 1 0.00 -0.96 0.07 0.61
Arava (Leflunomide)- FDA 14 Drug Disease Infection 766,637 1 0.00 -0.96 0.07 0.54
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis B 57,815 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Influenza 67,933 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Anemia 81,663 1 0.00 -0.96 0.07 0.58
Arava (Leflunomide)- FDA 14 Drug Disease Joint Pain 4,215 1 0.00 -0.96 0.07 0.65
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Ankylosing Spondylitis 9,665 1 0.00 -0.96 0.07 0.63
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58
Dronedarone Hydrochloride 14 Drug Disease Cancer 1,053,491 1 0.00 -0.96 0.07 0.53
Dronedarone Hydrochloride 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58